• M A Abd Razak, N A Ahmad, Y Y Chan, N Mohamad Kasim, M Yusof, M K A Abdul Ghani, M Omar, F A Abd Aziz, and R Jamaluddin.
• Institute for Public Health, Ministry of Health Malaysia, Jalan Bangsar, 50590 Kuala Lumpur, W.P. Kuala Lumpur, Malaysia. Electronic address: aznuddin.ar@moh.gov.my.
• Public Health. 2019 Apr 1; 169: 84-92.

ObjectivesThis systematic review aims to provide updated and comprehensive evidence on the validity and feasibility of screening tools for mild cognitive impairment (MCI) and dementia among the elderly at primary healthcare level.Study DesignA review of articles was performed.MethodsA search strategy was used by using electronic bibliographic databases including PubMed, Embase and CENTRAL for published studies and reference list of published studies. The articles were exported to a bibliographic database for further screening process. Two reviewers worked independently to screen results and extract data from the included studies. Any discrepancies were resolved and confirmed by the consensus of all authors.ResultsThere were three screening approaches for detecting MCI and dementia - screening by a healthcare provider, screening by a self-administered questionnaire and caretaker informant screening. Montreal Cognitive Assessment (MoCA) was the most common and preferable tool for MCI screening (sensitivity [Sn]: 81-97%; specificity [Sp]: 60-86%), whereas Addenbrooke's Cognitive Examination (ACE) was the preferable tool for dementia screening (Sn: 79-100%; Sp: 86%).ConclusionThis systematic review found that there are three screening approaches for detecting early dementia and MCI at primary health care. ACE and MoCA are recommended tools for screening of dementia and MCI, respectively.Copyright © 2019 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

14 keywords...

hide…